EFFICACY ANALYSIS OF DIFFERENT ANTIANGINAL REGIMENS IN ISCHEMIC HEART DISEASE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

EFFICACY ANALYSIS OF DIFFERENT ANTIANGINAL REGIMENS IN ISCHEMIC HEART DISEASE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Aim. Assessment of effectiveness of different treatment regimens application for angina in coronary heart disease patients (CHD) with frequent exacerbations of chronic obstructive pulmonary disease (COPD).Material and methods. Totally, 60 patients included, with CHD and COPD, with frequent exacerbat...

Full description

Bibliographic Details
Main Authors:	K. O. Galeeva, A. I. Chesnikova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-12-01
Series:	Российский кардиологический журнал
Subjects:	antianginal therapy ischemic heart disease chronic obstructive pulmonary disease
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/485

Similar Items

Modern principles of chronic coronary heart disease management. The role of antianginal medications
by: S. Yu. Martsevich
Published: (2005-06-01)

Choosing an antianginal therapy strategy in patients with stable coronary artery disease in real clinical practice: the advantages of trimetazidine
by: E. V. Borisova, et al.
Published: (2021-09-01)

HEMODYNAMIC AEROBIC MECHANISMS OF EXERCISE TOLERANCE INCREASE IN STABLE ANGINA PATIENTS ON ANTIANGINAL TREATMENT
by: A. P. Vasiliev, et al.
Published: (2017-12-01)

ASSESSMENT OF ANTIISCHEMIC AND ANTIANGINAL EFFECTS OF NICORANDIL BY TREADMILL TEST, UNDER THE FRAMEWORK OF KVAZAR STUDY
by: V. P. Voronina, et al.
Published: (2017-03-01)

Clinical and Anamnestic Features of Patients with Ischemic Heart Disease and Chronic Obstructive Pulmonary Disease
by: Oybek Urinov, et al.
Published: (2025-03-01)

THE INFLUENCE OF CONCOMITANT CARDIOVASCULAR PATHOLOGY (ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION) ON THE CHANGES OF RIGHT VENTRICLE OF HEART IN MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2012-09-01)

EFFECT OF NICORANDIL ON ENDOTHELIAL FUNCTION PARAMETERS AND SILENT MYOCARDIAL ISCHEMIA IN MEN WITH STABLE ANGINA
by: Haravenka I., et al.
Published: (2020-03-01)

Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients
by: Meng K, et al.
Published: (2024-10-01)

Spectral temporal mapping parameters of ventricular complex during antianginal therapy
by: Kh. Kh. Shugushev, et al.
Published: (2004-02-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

INFLUENCE OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON POST-OPERATION COURSE IN CORONARY HEART DISEASE
by: A. S. Klinkova, et al.
Published: (2016-04-01)

Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
by: N Yu Grigoryeva, et al.
Published: (2019-01-01)

Problems of diagnosis and treatment of chronic ischaemic heart disease combined with chronic obstructive pulmonary disease according to retrospective analysis
by: V.A. Potabashnii, et al.
Published: (2021-06-01)

Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01)

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease
by: Almagro P, et al.
Published: (2020-04-01)

The Risk of Ischemic Stroke in Patients with Chronic Obstructive Pulmonary Disease and Atrial Fibrillation
by: Hsien-Lung Tsai, et al.
Published: (2025-01-01)

Possibilities of nicorandil for coronary insufficiency correction in patients with ischemic heart disease and diabetes mellitus type 2
by: Zh. M. Sizova, et al.
Published: (2019-01-01)

Aortic stiffness in chronic obstructive pulmonary disease concurrent with coronary heart disease
by: Vera Afanas'evna Nevzorova, et al.
Published: (2010-03-01)

THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017-01-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYNAMICS OF MORPHOFUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE NORTH
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

Osteopontin in patients with chronic obstructive pulmonary disease and coronary heart disease
by: Natalia A. Suvorova, et al.
Published: (2023-05-01)

Chronic obstructive pulmonary disease and heart failure: research and clinical practice in primary care
by: Francesco Chiumeo, et al.
Published: (2015-12-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease.
by: V. A. Potabashniy
Published: (2018-10-01)

Study of Heart Rate Variability in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
by: M. E. Statsenko, et al.
Published: (2021-08-01)

Chronic Obstructive Pulmonary Disease and Heart Failure: Closer than Close
by: Jelena Ostojić, et al.
Published: (2017-01-01)

Efficiency of vaccine prophylaxis concentrated pneumococcal vaccine in patients with chronic obstructive lung disease and chronic heart failure
by: G L Ignatova, et al.
Published: (2018-08-01)

Risk prediction model for deterioration of heart failure in patients with chronic obstructive pulmonary disease
by: ZOU Xinliang, et al.
Published: (2024-01-01)

Clinical Features and the NT-proBNP Marker in Patients with Chronic Heart Failure in the Setting of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Т. A. Dzyurich, et al.
Published: (2019-09-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

Prognostic value of the post-exercise heart rate recovery and BHDE-index in chronic obstructive pulmonary disease
by: Shih-Yu Chen, et al.
Published: (2023-07-01)

Characteristics, Treatment, and Prognosis of Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Colombian Heart Failure Registry (RECOLFACA)
by: Jorge Alberto Sandoval-Luna, et al.
Published: (2024-08-01)

Influence of concomitant chronic obstructive pulmonary disease on left ventricular-arterial interaction in patients with ischemic cardiomyopathy
by: E. I. Myasoedova, et al.
Published: (2019-03-01)

The effect of individual exercise rehabilitation program on ischemic burden and cardiac function in patients with ischemic non-obstructive coronary heart disease: a randomized parallel controlled clinical trial
by: Yuan Wen, et al.
Published: (2025-03-01)

Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care
by: Nathaniel M. Hawkins, et al.
Published: (2023-12-01)